BRKR241115C60000
- 4.60
- 0.000.00%
Bruker Corp Newsroom
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $78
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics Against NanoString's CosMx SMI Products
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Investors Appear Satisfied With Bruker Corporation's (NASDAQ:BRKR) Prospects
Is Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now?
Leerink Partners Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $90
Bruker Price Target Announced at $75.00/Share by Barclays
Bruker Initiated at Overweight by Barclays
Barclays Initiates Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $75
Bruker Announces Formation of New Bruker Spatial Biology Division
BRKR Stock Might Gain From the Newly Launched OptoVolt Module
Bruker Corporation (NASDAQ:BRKR) Delivered A Better ROE Than Its Industry
Express News | Bruker Corp: Bruker Biospin Acquires Bridge12 EPR Business
Bruker Introduces Innovative Neuroscience Research Solution With High-Speed OptoVolt Voltage Imaging
Express News | Bruker Corp : BofA Global Research Cuts Price Objective to $79 From $82
Express News | Bruker Corp - Financial Details of Transaction Were Not Disclosed
Bruker Acquires Dynamic Biosensors, A Pioneer Of Single-Cell Interaction Cytometry Systems For Drug Discovery >BRKR
Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery